Christopher Foti
Family Medicine · Opelousas, LANPI 1841401957
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $671 and has fallen 89.1% since, to $73 in 2025.
Across 66 payments — averaging $14.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$217
- AbbVie$102
- Bristol Myers Squibb$89
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$73
- Lilly USA, LLC$72
- Boehringer Ingelheim$64
- plus $354 from 15 others
What the payments were for
- Food & beverage$971100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $217 |
| AbbVie(2 entities) | 6 | $102 |
| Bristol Myers Squibb | 4 | $89 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $73 |
| Lilly USA, LLC | 6 | $72 |
| Boehringer Ingelheim | 5 | $64 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| GSK | 3 | $42 |
| Shire North American Group Inc | 3 | $39 |
| Astellas Pharma US Inc | 2 | $36 |
| AstraZeneca | 2 | $34 |
| Amgen | 2 | $30 |
| Currax Pharmaceuticals LLC | 2 | $25 |
| Amarin Pharma, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Abbott | 1 | $13 |
| Pfizer | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $12 |
| Circassia Inc. | 1 | $12 |
| Novartis | 1 | $11 |
How this compares
$971 in reported general payments places this provider in the 55th percentile of 1,469 family medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 13 | $54 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Opelousas
- Christine SmithBaton Rouge$185K
- Thomas DansbyMonroe$169K
- Michael FlemingShreveport$165K
- Robert St AmantGonzales$156K
- William HathawaySpringhill$105K
- Cesar GonzalesWest Monroe$94K
- Phillip ConnerSulphur$71K
- Richard JeansonneMandeville$49K
- Leonard TreanorHammond$29K
- Shannon HaasMandeville$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.